METHOD OF SELECTING PATIENTS FOR TREATMENT WITH A COMBINATION OF AN AXL INHIBITOR AND AN IMMUNE CHECKPOINT MODULATOR
Publication
EP4138823A1
Kind: A1
Mar 18, 2026
Applicants
BerGenBio ASA, The Board of Regents of the University of Texas System
Inventors
LORENS, James, MICKLEM, David, LI, Huiyu, LIU, Zhida, MINNA, John, BREKKEN, Rolf
IPC Classifications
A61K 31/4196 20060101AFI20211029BHEP
A61K 45/06 20060101ALI20211029BHEP
A61P 35/00 20060101ALI20211029BHEP
A61K 39/00 20060101ALI20211029BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR